Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

National Drug Formulary

INDIUM (IN111) CHLORIDE INJECTION 370 MBQ/ML [SIN10571P]

Active ingredients: INDIUM (IN-111) CHLORIDE

View product's general information
Last updated on 9 October 2026

Product Info

INDIUM (IN111) CHLORIDE INJECTION 370 MBQ/ML

[SIN10571P]

Product information

Active Ingredient and Strength

INDIUM (IN-111) CHLORIDE - 370 MBQ/ML AT ART

Dosage Form

INJECTION

Manufacturer and Country

CURIUM NETHERLANDS B.V. - NETHERLANDS

Registration Number

SIN10571P

Licence Holder

QT INSTRUMENTS (S) PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

V09IB

Prescription-only Medicines with Exemptions for Supply without Prescription

NA

Indication

4.1 Therapeutic indications
This product is for diagnostic use only.

Indium (In111) chloride is used as an ingredient for the radiolabelling of certain suitably derivatised proteins which are subsequently administered intravenously for a variety of investigative purposes using appropriate imaging procedures.

Indium (In111) chloride is used extensively for the radiolabelling of monoclonal antibodies. The nature of the disease state to be investigated will be determined by the particular monoclonal antibody to be labelled.

Indium (In111) chloride has also been used as the radiolabelling ingredient in injectable preparations such as Indium (111In)-labelled proteins.

Dosing

4.2 Posology and method of administration
The vial contains a sterile aqueous solution for the in-vitro radiolabelling of suitable conjugated proteins such as monoclonal antibodies, which are subsequently administered intravenously.

The quantity of Indium (111In) chloride required for radiolabelling and the quantity of Indium (111In)-labelled pharmaceutical that is subsequently administered will depend on the pharmaceutical being labelled and its intended use. Information on recommended dosage and administration will be provided by the manufacturer of the pharmaceutical to be radiolabelled.

The activity to be administered to children may be calculated approximately by correcting on a weight, body surface area or age basis the activity to adults. For the newborn and children under about one year of age, the target organ size in relation to the whole body must also be taken into consideration.

Contraindications

4.3 Contraindications
Information on contra-indications to particular Indium (111In)-labelled pharmaceuticals prepared by radiolabelling with Indium (111In) chloride will be supplied by the manufacturer of the pharmaceutical to be radiolabelled.